Autres langues Ventripoint Diagnostics Ltd.

Actions

VPT

CA92281P2008

Marché Fermé - Toronto S.E. Autres places de cotation 21:57:12 10/05/2024			Varia. 5j.	Varia. 1 janv.
0,245 ^CAD	0,00%		-2,00%	-16,95%

30/04	Ventripoint Diagnostics Ltd. annonce ses résultats pour l'exercice clos le 31 décembre 2023	CI
04/03	Ventripoint Diagnostics Ltd. publie une mise à jour importante de la conception et de la fonction de son système d'analyse du cœur entier (VMS+3.2)	CI

Autres langues

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

Ventripoint's Next Generation, AI-powered Heart-scanning Technology Submitted to U.S Food and Drug Administration	06/05
Duke University Health Center -- One of America's Top Heart-care Institutions and Innovators -- Purchases Ventripoint's AI Heart-scan Technology	01/05
Ventripoint Diagnostics Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	30/04
VentriPoint Diagnostics Ltd. announced that it expects to receive CAD 3 million in funding	11/04
Ventripoint Diagnostics Provides Corporate Update and Announces Conference Call	28/03
Ventripoint Diagnostics Ltd. Releases Significant Upgrade to the Design and Function of Its Whole-Heart Analysis System (VMS+3.2)	04/03
Enhanced Design Breakthrough Makes Ventripoint's VMS+ Even Simpler to Use	04/03
Ventripoint Diagnostics Ltd. Showcases A.I. Powered Heart-Scanning Technology at International Cardiology Conferences	20/02
Ventripoint Successfully Showcases A.I.-Powered Heart-Scanning Technology at Prestigious International Cardiology Conferences	20/02
Ventripoint Announces Changes to The Board of Directors	13/02
Ventripoint Diagnostics Ltd. Appoints Hugh Macnaught as Interim CEO	05/02
Ventripoint Diagnostics Ltd. Appoints Hugh Macnaught as President	05/02
Ventripoint Begins 2024 with Leadership Change	05/02
The Paediatric Heart Centre At the Medical University of Vienna Has Chosen to Adopt the Vms+ as Its Cardiac Diagnostic Tool	01/02
The Medical University of Vienna's Paediatric Heart Centre Purchases Ventripoint's AI-Powered Heart Imaging System	01/02
The 2023 Year in Review	29/01
Dr. Luc Mertens, Head of Echocardiography at The Hospital for Sick Children, Joins Ventripoint's Clinical Advisory Board	22/01
VentriPoint Diagnostics Ltd. Announces Appointment of Dr. Luc Mertens to Clinical Advisory Board	21/01
Rising Nanocap Stars of Medical Technology (TBRIF, PROF, VPTDF, ATBPF)	04/01
Ventripoint Whitepaper Distribution	03/01

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Autres langues Ventripoint Diagnostics Ltd.

Actions

VPT

CA92281P2008

Autres langues

Filtres